Research.Patient.info
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2 Study of Oral LOXO-305 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
This study is testing a new drug, LOXO-305, for people with certain types of blood cancer like CLL/SLL and NHL. It's an early-stage trial looking at how safe the drug is, what dose works best, and if it helps shrink cancer.
Poland · France · Italy - recruitingPHASE1
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
This study is testing a new medicine called EXS73565 for people with certain types of B-cell cancers that have come back or not responded to usual treatments. We want to find a safe dose and see how it works.
Georgia · Moldova · Spain